RxDoctor Payments Data

Paul Buller, MD

Family Medicine · Goshen, INNPI 1750328043

Payments from drug & device makers

$1,775in general payments, 2019–2025

Across 105 payments — averaging $16.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$395
  • Boehringer Ingelheim$252
  • Novartis$145
  • AstraZeneca$141
  • AbbVie$98
  • Sunovion Pharmaceuticals Inc.$98
  • plus $645 from 18 others

What the payments were for

  • Food & beverage$1,75699%
  • Education$191%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,775 in reported general payments places this provider in the 70th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$249,639
Medicare patients
452
Services billed
3,670

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban1,145$256,147
JardianceEmpagliflozin174$113,090
XareltoRivaroxaban279$80,648
FarxigaDapagliflozin Propanediol369$70,527
TrulicityDulaglutide111$68,971
BriviactBrivaracetam45$39,692
Trelegy ElliptaFluticasone/Umeclidin/Vilanter49$36,911
GemtesaVibegron178$35,980
Breo ElliptaFluticasone/Vilanterol54$28,794
JanuviaSitagliptin Phosphate35$27,998
TradjentaLinagliptin168$24,656
MyrbetriqMirabegron112$22,508
AptiomEslicarbazepine Acetate53$16,730
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog79$13,555
Spiriva HandihalerTiotropium Bromide20$13,272

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$395$260,6861,172 claims
Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat$252$146,417354 claims
Johnson & JohnsonXarelto$78$80,648279 claims
AstraZenecaFarxiga$141$70,527369 claims
Lilly USA, LLCTrulicity$89$68,971111 claims
MerckJanuvia$15$27,99835 claims
Astellas Pharma US IncMyrbetriq$16$22,508112 claims
AbbVieLinzess, Restasis$98$19,50539 claims
Sunovion Pharmaceuticals Inc.Aptiom$98$16,73053 claims
Novo NordiskOzempic$76$11,61611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Goshen

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →